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Abstract
Background: Coronary artery bypass grafting (CABG) is one the most common heart operations, in which blood vessels from other
parts of the body, like the saphenous vein, are grafted to the blocked arteries. Due to the widespread use of vasoactive drugs in
the course of surgery, and renal complications of these drugs, we aimed to determine the effect of norepinephrine on the renal
function of patients with CABG, visiting the cardiac surgery ward of a university affiliated hospital in Ardabil, Iran, with the purpose
of maintaining renal perfusion and preventing renal dysfunction in patients undergoing CABG.
Objectives: This research aimed to determine and compare the effects of vasopressin and norepinephrine on the renal function of
patients undergoing CABG.
Methods: This study was a randomized clinical trial. A total of 120 candidates for CABG in a governmental hospital, Iran, during
years 2016 - 2017, were randomly assigned into two groups. The patients’ conditions across the two groups were compared regarding
hemodynamics during surgery and post-surgical complications, e.g., renal function (Bun, Cr, and CLCr), using a researcher made
questionnaire.
Results: The results of our study showed that according to repeated measures test, there was no statistically significant difference
during the intervention (P value > 0.05). However, the Independent t-test revealed a statistically significant difference between
groups following CABG, which related to the clearance creatinine level. It indicated higher clearance creatinine level in the nore-
pinephrine group (72.83± 25.03 and 78.16± 27.31) than the vasopressin group (64.33± 17.47 and 86.33± 30.54) (P < 0.05), however,
the groups did not vary significantly from each other in other items.
Conclusions: According to the results of the study, it could be stated that probable renal complications during operation can be
reduced to some extent in patients undergoing CABG using inotrope and vasopressor drugs such as norepinephrine.
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1. Background
One of the most prevalent types of heart operations is
the Coronary artery bypass grafting (CABG), in which blood
vessels from other areas of the body, like the saphenous
vein, are bypassed to the blocked artery, in order for the
blocked path to be improved (1). This operation is consid-
ered as a basic method for treating cardiovascular diseases.
In these patients, hypoperfusion may lead to kidney failure
(2), a physiologic condition that reduces blood circulation,
without damage to the renal tubules, and is considered as
a pre-renal failure. Reduction of arterial perfusion leads
to a reduction in the amount of blood filtration through
glomeruli. When the perfusion pressure is less than 70
mm, self-regulating protection mechanism breaks down
and causes further reduction in the kidney’s glomerular
filtration, if the reduction of perfusion persists, it can re-
sult in an irreversible damage to kidney tubules (1). In fact,
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during surgery, in addition to liquid loss and myocardial
depression, peripheral vasodilatation, as an effect of anes-
thetics, can lead to kidney perfusion; therefore, attend-
ing to fluid replacement and vasoconstrictors is of high
value (3). Vasopressin is a vasoconstrictor drug. This hor-
mone, other than an amino acid, is similar to oxytocin,
however, its physiologic effect is completely different. In
addition to anti-urogenital therapy, vasopressin is neces-
sary for vascular hemostasis. Vasopressin has several recep-
tors. Among the vascular receptors that are located on the
smooth muscles and platelets and cause vascular contrac-
tion and prostaglandin secretion (4).
Stefan et al. showed that when vasopressin is admin-
istered to patients with low blood pressure resulting from
trauma, less fluid is required.
In addition, Managho et al. estimated the mortality
rate after revascularization of the coronary artery in pa-
tients with normal renal function at 0.9%, and in those
with renal dysfunction 63% (4). It is also mentioned in
a research that hemophilic patients as well as those with
mild Von Willebrand factor (VWF) deficiency benefit from
the administration of vasopressin during CABG (5). Acute
kidney failure, regardless of its cause, has a mortality rate
of 50% (6). Annually, in the United States, 50 billion dol-
lars are spent on performing this surgery (7). Therefore,
despite the advances in CABG and anesthesia, renal fail-
ure remains a major problem surrounding CABG. More-
over, considering the prevalence of inotropic drug use dur-
ing CABG, the renal complications of long-term consump-
tion of these drugs, and the necessity of choosing low-risk
medicine, if vasopressin is of less renal complications, can
be used as an inotropic drug. Therefore, we aimed at in-
vestigating the effect of vasopressin on reducing bleeding
and maintaining renal perfusion and preventing renal dys-
function in patients undergoing CABG, compared to nore-
pinephrine that is used to improve the overall survival rate
among these patients.
2. Methods
2.1. Study Design/Sample
This randomized clinical trial study was performed
with patients who were candidates for CABG and had been
referred to the surgery department in the Imam Khome-
ini Hospital (governmental) of Ardabil over two years (2016
- 2017). A total of 120, i.e., 60 cases in each group, with
95% confidence and 80% test strength were included in the
present study using Equation 1.
(1)n =
2
(
Z1−α
2
+ Z1−β
)2
P (1− P )
(P0 − P1)2
2.2. Materials and Methods
The study patients were randomly selected from CABG
candidates admitted to the Imam Khomeini Hospital Car-
diac Surgery ward. They were homogenized in terms
of age, sex, and renal function (Bun, Cr, and CLCr), as
well as the mean arterial blood pressure. It means that,
the selection of both groups was in the form of double-
blind and was based on their similarity in their age range,
sex, normal laboratory tests results, and the mean arte-
rial pressure under the same CPB-pump. The participants
were assigned into two groups of intervention and con-
trol by blocked randomization using cards in random
blocks. Both groups during surgery underwent cardiopul-
monary bypass (CPB). To control the mean arterial blood
pressure, norepinephrine was administered to the first
group during CPB to maintain their hemodynamics. A
norepinephrine ampule (Noradrenaline, aguettant Ltd.,
Lyon, France) was diluted with 50 mL normal saline and
was infused by a syringe-pump. The norepinephrine dose
was 0.05 to 0.5 µg / kg / minute, which started when
the mean arterial pressure was below 50 mmHg, and ta-
pered and stopped when the pressure was above 50 - 60
mmHg. In addition, for the maintenance of hemodynam-
ics in patients in the second group, 0.02 u/kg/minute vaso-
pressin (Vasostrict®, Par Pharmaceutical Companies, Inc.,
N.Y, USA) was diluted and infused with normal saline, and
was monitored. Then, based on a researcher-made ques-
tionnaire, the patients’ hemodynamics, including renal
function (Bun, Cr, CLCr), was compared across two groups
during surgery and after surgery. To determine the valid-
ity, the questionnaire was evaluated by a group of profes-
sors and experts. A test-retest method was used to deter-
mine the reliability of the questionnaire. In addition, Cron-
bach’s alpha coefficient was also used to determine the in-
ternal consistency of the questionnaire. Cronbach’s alpha
coefficient was 0.88.
The study was approved by the Ethics Committee of
the Tehran University of Medical Sciences. Furthermore,
researchers followed the Helsinki Declaration for medical
research including human subjects. An informed writ-
ten consent form was signed by each participant. The
study was registered at the Iranian Registry of Clinical Tri-
als (IRCT), available at http://irct.ir/, with registration num-
ber of "IRCT201412054256N4".
2.3. Inclusion Criteria
- Age over 30
- Not responding to medical drugs
- Urgency of undergoing CABG
- Confirmation of angiography result regarding coro-
nary artery involvement
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2.4. Exclusion Criteria
- Absence of chronic renal failure
- High levels of creatinine (over 1.5)
- Diabetes
- Hypertension
2.5. Statistical Analysis
Data analysis was done using IBM SPSS Statistics Soft-
ware of Windows, version 21.0 (IBM Corp., Armonk, N.Y.,
USA) through descriptive and inferential statistics such as
Chi-square, paired t-test, Independent t-test, and repeated
measures. The level of significance was considered at P <
0.05. In addition, if participants leave the study, despite the
necessary explanations, the Intention to treat approach
and the per-protocol support method was applied for data
analysis. However, no value was missed.
3. Results
The results of the study indicated that the participants
in this study were homogenous considering age, height,
weight, gender, place of residence, educational level, blood
type (Table 1), systolic blood pressure, diastolic blood pres-
sure, mean arterial blood pressure, and heart rate (Table 2),
and the effect of dependent variables on independent vari-
ables were controlled.
In addition, the findings of this study showed that be-
fore and after the intervention the level of creatinine clear-
ance in the norepinephrine group and vasopressin group
was (72.83± 25.03 and 78.16± 27.31), and (64.33± 17.47and
86.33± 30.54), respectively.
According to the results of the repeated measures test,
there was no significant difference in the level of sodium,
potassium, urea, creatinine, and creatinine clearance in
the intervention (effect of norepinephrine before, during
and after surgery). However, there was no significant dif-
ference between the two groups (norepinephrine and va-
sopressin) in terms of sodium, potassium, urea, and cre-
atinine levels (P > 0.05); however, there was a significant
difference in creatinine clearance level (P = 0.03) and the
norepinephrine group had a higher creatinine clearance
level than the vasopressin group (Table 3 and Figure 1).
4. Discussion
Although cardiac surgery is a reliable method for im-
proving myocardial perfusion, it has multiple complica-
tions during and after surgery. One of the main problems
in renal damage is vascular spasm, which is especially seen
during CPB; conventional treatments and vasodilators are
not successful in removing it. When the vasopressor drugs
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Figure 1. Estimated marginal means of repeated measures
are used for various reasons, the process of renal injury
intensifies (8). If the vasopressor medicine exerts less im-
pact on vasospasm, it would be a more appropriate drug
for being pumped. The comparison of two drugs of vaso-
pressin and epinephrine in this study was made based on
the assumption that the adverse effects of vasopressin on
kidney vessels are lower than norepinephrine. As repeated
measures in this study showed, there was no significant
difference between the levels of sodium, potassium, urea,
creatinine, and creatinine clearance during the interven-
tion (the effect of norepinephrine before, during and after
surgery). Mahoori et al. (9), suggested in their study that
one of the most severe side-effects associated with heart
surgery is kidney failure, and the best process for main-
taining renal function is hydration during operation (10).
Thus, due to the sufficient hydration in the intervention
process, renal function had no significant depression.
Furthermore, there was no significant difference be-
tween the two groups (norepinephrine and vasopressin) in
terms of sodium, potassium, urea, and creatinine levels (P
> 0.05); however, there was a significant difference in cre-
atinine clearance level (P = 0.03), and the norepinephrine
group had higher levels of creatinine clearance than the va-
sopressin group. This means that patients with CABG who
received norepinephrine had a better renal function than
the vasopressin group. The concentration of serum creati-
nine is broadly subordinate to age, sex, muscle mass, mus-
cle metabolism, and drug administration (11). Its increased
concentration and sensitivity appear only when the dis-
ease progresses (12) and the decrease in glomerular filtra-
tion rate exacerbates creatinine tubule secretion. In ad-
dition, during acute glomerular filtration changes, serum
creatinine does not correctly predict renal function until it
reaches a balance basal usually two to three days after the
onset of injury (13, 14). Lin and colleagues also mentioned
serum creatinine level and urine volume, 24 hours prior to
surgery, as valuable information for the prediction of acute
renal failure in patients with CABG. However, the results
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Table 1. The Demographic Characteristics of Patients in Two Groups (Mean± SD)
Characteristics Norepinephrine Vasopressin P Valuea
Age (y) 62.80± 10.15 65.11± 9.80 0.20
Height (cm) 165.43± 9.81 164.43± 8.65 0.55
Weight (kg) 70.65± 10.14 70.88± 9.19 0.89
Ejection fraction (EF), (%) 47.41± 6.79 46.91± 7.97 0.71
Sex (n)
Male 45 43 0.17
Female 15 17 0.68
Angiography (number of involved vessels) 0.25
1 2 1
2 3 8
3 55 51
a P < 0.05 was considered significant.
Table 2. Hemodynamic Status of Patients in Two Groups (Mean± SD)
Norepinephrine Vasopressin Independent ta
Systolic blood pressure (mmHg)
Before surgery 125.65± 19.17 128.43± 17.12 0.40
After surgery 113.17± 10.97 111.98± 12.18 0.57
Diastolic blood pressure (mmHg)
Before surgery 78.16± 11/67 77.98± 9.5 0.92
After surgery 65.86± 10.96 67.06± 11.63 0.65
Mean arterial blood pressure (under pump) (mmHg)
During surgery 66.68± 3.42 67.60± 3.86 0.17
Heart rate (per minute)
Before surgery 75.88± 6.00 76.90± 5.14 0.32
During surgery 79.51± 6.97 79.86± 6.38 0.77
After surgery 85.00± 10.25 83.21± 12.24 0.38
a P < 0.05 was considered significant.
Table 3. Creatinine Clearance Level of Patients in Two Groups (Mean± SD)
Clearance Creatinine Evaluation Norepinephrin Vasopressine Independent t- Test Intervention Effect Repeated Measures
Before surgery 78.16± 27.31 86.33± 30.54 t = 1.54; df = 118; P = 0.12
df = 1; P = 0.64; F = 1.60During surgery 78.08± 25.38 83.70± 25.50 t = 1.20; df = 118; P = 0.22
After surgery 72.83± 25.03 64.33± 17.47 t = -2.15; df = 118; P = 0.033
of creatinine clearance were more accurate than other in-
dicators of renal function and showed the renal function
faster than creatinine. The obtained results in this study
conforms to the finding of study of Lin et al. (15), as well.
Pilarczyk and his colleagues suggested sensitive and
specific biomarkers, such as TIMP and IGFBP, as appropri-
ate means for early diagnosis of acute renal damage af-
ter CABG compared to serum creatinine (16). Canty and
Kim also stated that during heart surgery, low dose routine
norepinephrine infusion is due to the reduction of hemod-
ilogue and blood transfusion without serum creatinine in-
crease (17). Morimatsu et al. (18), also reported in their
study that norepinephrine does not increase the serum
creatinine concentration after cardiac surgery in patients
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with hypotension. Moreover, the study of Hagen Ewa and
colleagues, in 2016, indicated that the administration of
norepinephrine is helpful for maintaining the mean blood
pressure about 80 mmHg during CABG. However, main-
taining the mean arterial blood pressure was done without
reducing O2 saturation (19). The results of their study were
consistent with ours in that the mean arterial blood pres-
sure was maintained about 70 to 80 mm Hg during CABG.
The study conducted by Yimin Ho and colleagues, in
China in 2013, showed that vasopressin is better than nore-
pinephrine in maintaining a stable hemodynamic status.
Their study was performed on 10 patients treated with va-
sopressin and 10 patients treated with epinephrine (20).
The present study was conducted with 60 patients in each
group (vasopressin and norepinephrine) to reduce the er-
ror arising from low sample size. In addition, it was shown
that there was no significant difference in hemodynamic
parameters between the two groups.
Similarly, Krejci et al. (21), concluded that vasopressin
causes a significant reduction in blood flow to the kidneys.
They have also noted that the increase in urinary output is
not due to the proper function of the kidneys. The results
of this study are consistent with the present study that
indicates that vasopressin did not have a beneficial effect
on the maintenance of renal function. In the study con-
ducted by Jayanta Kay et al., titled as "Vasopressin: Its role
in anesthesia", which was done over 10 years of ongoing
research, vasopressin has been recommended as the best
vasopressor. They suggest that clinical and experimental
studies support the effect of low dose vasopressin infusion
in vasodilator shock. They have also claimed that although
this medication increases arterial blood pressure and pos-
sibly increases urinary output, there is not enough support
for using vasopressin and its usefulness in septic shock
and other cases (22). In this study, they also attributed
the mean arterial blood pressure rise to the effect of vaso-
pressin, however, no difference was reported between the
efficacy of vasopressor and norepinephrine. In the same
vein, the the present study didn’t find sufficient evidence
to support the efficacy of vasopressin. Miller’s study, in
2015, also showed that use of vasopressin with or without
epinephrine had no benefit for the survival of those un-
der treatment (23), which is in line with the results of the
present study, suggesting that the use of vasopressin didn’t
have any superiority over norepinephrine regarding main-
taining renal function. Besides, due to the high cost of va-
sopressin, it is not recommended to be used.
It should be noted that there were some factors that
confined our study such as time limit, number of people,
number of CABG surgeries, and considering the fact that
Imam Khomeini Hospital (RA) was the only heart surgery
center in the province. Therefore, it is suggested that
this study be replicated in other cities as well as in more
equipped centers.
4.1. Conclusion
In the present study, only the level of creatinine clear-
ancehad a significant difference (P = 0.03) after surgery,
and norepinephrine group had higher levels of creatinine
clearance than the vasopressin group. This means that the
candidates for CABG, who were receiving norepinephrine,
had a better renal function than the patients receiving va-
sopressin. However, in regards to sodium, potassium, urea,
and creatinine levels no statistically significant difference
was detected between the groups (P > 0.5). In addition,
there is not noticeable superiority of vasocontriction ef-
fect of one drug over the other one (vasopressin and nore-
pinephrine) in patients who were candidates for CABG.
Furthermore, since the cost of vasopressin is higher
than norepinephrine, it is better nor-epinephrine to be
used in this group of patients.
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